Rhumbline Advisers Inovio Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q4 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.38 - $0.58 $6,158 - $9,399	-16,206 Reduced 67.9%	7,661 $2,000
Q2 2023 Aug 08, 2023	SELL	$0.39 - $0.94 $142,729 - $344,015	-365,974 Reduced 93.88%	23,867 $10,000
Q1 2023 May 11, 2023	BUY	$0.79 - $1.91 $14,092 - $34,072	17,839 Added 4.8%	389,841 $320,000
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $6,698 - $11,877	4,751 Added 1.29%	372,002 $580,000
Q3 2022 Nov 10, 2022	BUY	$1.66 - $2.79 $79,103 - $132,951	47,653 Added 14.91%	367,251 $634,000
Q2 2022 Aug 11, 2022	BUY	$1.44 - $3.98 $47,028 - $129,982	32,659 Added 11.38%	319,598 $553,000
Q1 2022 May 12, 2022	SELL	$2.97 - $5.2 $88,651 - $155,214	-29,849 Reduced 9.42%	286,939 $1.03 Million
Q4 2021 Feb 10, 2022	SELL	$4.99 - $7.46 $9,895 - $14,793	-1,983 Reduced 0.62%	316,788 $1.58 Million
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $48,029 - $65,000	6,708 Added 2.15%	318,771 $2.28 Million
Q2 2021 Aug 05, 2021	BUY	$6.23 - $10.03 $557,292 - $897,213	89,453 Added 40.18%	312,063 $2.89 Million
Q1 2021 May 06, 2021	BUY	$8.81 - $16.96 $152,078 - $292,763	17,262 Added 8.41%	222,610 $2.07 Million
Q4 2020 Feb 10, 2021	BUY	$8.5 - $12.85 $92,582 - $139,962	10,892 Added 5.6%	205,348 $1.82 Million
Q3 2020 Nov 12, 2020	SELL	$9.57 - $27.05 $315,331 - $891,297	-32,950 Reduced 14.49%	194,456 $2.26 Million
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $686,796 - $3.05 Million	96,190 Added 73.31%	227,406 $6.13 Million
Q1 2020 May 06, 2020	BUY	$2.98 - $14.09 $7,682 - $36,324	2,578 Added 2.0%	131,216 $976,000
Q4 2019 Feb 05, 2020	BUY	$1.97 - $3.72 $10,421 - $19,678	5,290 Added 4.29%	128,638 $425,000
Q3 2019 Oct 23, 2019	SELL	$2.05 - $3.02 $1,844 - $2,718	-900 Reduced 0.72%	123,348 $253,000
Q2 2019 Aug 14, 2019	BUY	$2.29 - $4.1 $27,273 - $48,830	11,910 Added 10.6%	124,248 $365,000
Q1 2019 May 01, 2019	BUY	$3.34 - $5.1 $8,834 - $13,489	2,645 Added 2.41%	112,338 $419,000
Q4 2018 Jan 31, 2019	BUY	$3.89 - $6.11 $140,137 - $220,112	36,025 Added 48.9%	109,693 $439,000
Q3 2018 Nov 07, 2018	SELL	$3.92 - $5.58 $20,599 - $29,322	-5,255 Reduced 6.66%	73,668 $410,000
Q2 2018 Aug 06, 2018	BUY	$3.88 - $5.16 $17,673 - $23,503	4,555 Added 6.12%	78,923 $309,000
Q1 2018 May 02, 2018	BUY	$4.05 - $5.69 $10,773 - $15,135	2,660 Added 3.71%	74,368 $350,000
Q4 2017 Feb 09, 2018	SELL	$4.13 - $6.68 $28,563 - $46,198	-6,916 Reduced 8.8%	71,708 $296,000
Q3 2017 Nov 06, 2017	BUY	$5.36 - $6.37 $421,424 - $500,834	78,624	78,624 $498,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account